Ohtsubo Korenori, Sata Michio, Kawaguchi Takumi, Morishige Satoshi, Takata Yuka, Oku Eijiro, Imamura Rie, Seki Ritsuko, Hashiguchi Michitoshi, Osaki Koichi, Yakushiji Kazuaki, Kanaji Taisuke, Yoshimoto Kohji, Ueno Takato, Okamura Takashi
Division of Hematology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan.
Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
Int J Hematol. 2009 May;89(4):452-459. doi: 10.1007/s12185-009-0301-x. Epub 2009 Apr 8.
To investigate the association between hepatitis C virus (HCV) and B cell proliferation, we searched for the clonal B cells by flow cytometric analysis of the surface immunoglobulin kappa (kappa):lambda (lambda) light chain ratios of the circulating B (CD19+) cells in 240 HCV-positive patients and 150 negative controls with liver diseases. Clonal B cells with light chain restriction (kappa:lambda ratio >3:1 or <1:2) were analyzed for CD5 expression and the presence of monoclonal immunoglobulin heavy-chain (IGH) gene rearrangements and the t(14;18) chromosomal translocation. Clonal B cells were detected in 7 cases with HCV (2.9%), but was never detected in the controls (p < 0.05). Of the 7 cases, all had monoclonal IGH gene rearrangements and one had the t(14;18) chromosomal translocation. These HCV-related clonal B cells are not uniform in the intensity of CD5 expression and showed no increase in the frequencies of CD5+ population compared with non-clonal B cells. No "chronic lymphocytic leukemia-phenotype" cells were found. The loss of clonality was observed in 2 cases treated with interferon and in one case treated with splenectomy. The longitudinal study is required to determine whether these circulating clonal B cells progress to lymphoproliferative disorders in future or not.
为了研究丙型肝炎病毒(HCV)与B细胞增殖之间的关联,我们通过流式细胞术分析了240例HCV阳性患者和150例肝病阴性对照者循环B(CD19 +)细胞的表面免疫球蛋白κ(κ):λ(λ)轻链比率,以寻找克隆性B细胞。对具有轻链限制(κ:λ比率> 3:1或<1:2)的克隆性B细胞进行CD5表达分析以及单克隆免疫球蛋白重链(IGH)基因重排和t(14; 18)染色体易位的检测。在7例HCV患者中检测到克隆性B细胞(2.9%),但在对照组中未检测到(p <0.05)。在这7例患者中,所有患者均有单克隆IGH基因重排,1例有t(14; 18)染色体易位。这些与HCV相关的克隆性B细胞在CD5表达强度上并不一致,与非克隆性B细胞相比,CD5 +群体的频率没有增加。未发现“慢性淋巴细胞白血病表型”细胞。在接受干扰素治疗的2例患者和接受脾切除术治疗的1例患者中观察到克隆性丧失。需要进行纵向研究以确定这些循环克隆性B细胞未来是否会发展为淋巴增殖性疾病。